Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

53
Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 -

Transcript of Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Page 1: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Chapter 10

Eternal Life: Cell Immortalization and Tumorigenesis

-10.1 ~ 10.9 -

May 1, 8 & 15, 2007

Page 2: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

10.1 Normal cell populations register the number of cell generations separating them from their ancestors in the early embryo

- Normal cells have a limited proliferative potential.

- Cancer cells need to gain the ability to proliferate indefinitely – immortal.

- The immortality is a critical component of the neoplastic growth program.

Page 3: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.2 The Biology of Cancer (© Garland Science 2007)

Escape from senescence and become immortal or even further transformed to malignant cells.

Page 4: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

“Hayflick limit” of fibroblasts in the culture

Page 5: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.3 The Biology of Cancer (© Garland Science 2007)

proliferating human senescent cells in culture fibroblasts - “fried egg” morphology - remain metabolically active, but lost the ability to re-enter into the active cell cycle - the downstream signaling pathways seem to be inactivated

Replicative senescence in vitrosenescence-associated acidic β-galactosidase

Page 6: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.3 The Biology of Cancer (© Garland Science 2007)

proliferating cells senescent cells

senescence associated β-galactosidase

(lysosomal β-D-galactosidase)

Page 7: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.4b The Biology of Cancer (© Garland Science 2007)

Young and old keratinocytes in the skin

Keratinocyte stem cells in the skin lose proliferative capacity with increasing age.

Page 8: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Cancer cells and embryonic stem cells share some replicative properties

- Embryonic stem (ES) cells show unlimited replicative potential in culture and are thus immortal.

- The replicative behavior of cancer cells resembles that of ES cells.

- Many types of cancer cells seem able to proliferate forever when provided with proper in vitro culture conditions.

- HeLa cells (Henrietta Lacks, 1951): - the 1st human cell line and 1st human cancer cell line established in culture

- derived from the tissue of cervical adenocarcinoma

Page 9: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

10.2 & 3 Cells need to become immortal in order to form cancers

Two regulatory mechanisms to govern the replicative capacity of cells:

1. senescence - Cumulative physiologic stress over extended periods of time halts further proliferation. These cells enter into a state of senescence.

cumulation of oxidative damage contributes to senescence, e.g., reactive oxygen species (ROS), DNA damage

2. crisis - Cells have used up the allowed “quota” of replicative doublings. These cells enter into a state of crisis, which leads to apoptosis.

Page 10: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.10 The Biology of Cancer (© Garland Science 2007)

Cell populations in crisis show widespread apoptosis

Page 11: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Cell senescence does occur in vivo

Figure 10.9c The Biology of Cancer (© Garland Science 2007)

senescence-associated β-galactosidase

(SA-β-gal)

Treatment of lung cancer with chemotherapeutic drugs appear to induce senescence in tumor cells

Page 12: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Barbara McClintoch discovered (1941) specialized structures at the ends of chromosomes, the telomeres, that protected chromosomes from end-to-end fusions.

(She also demonstrated movable genetic elements in the corn genome, later called transposons.)

- Nobel prize in Physiology & Medicine in 1983

10.4 The proliferation of cultured cells is limited by the telomeres of their chromosomes

Page 13: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Telomeres detected by fluorescence in situ hybridization(FISH)

telomeric DNA

Page 14: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.11b The Biology of Cancer (© Garland Science 2007)

The telomeres lose their protective function in cells that have been deprived of TRF2, a key protein in maintaining normal telomere structure.

In an extreme form, all the chromosomes of the cell fused into one giant chromosome.

Page 15: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.14a The Biology of Cancer (© Garland Science 2007)

Mechanisms of breakage-fusion-bridge cycles

2 sister chromatids during the G2 phase of the cell cycle

Page 16: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.14b, c The Biology of Cancer (© Garland Science 2007)

truncationtranslocationaneuploidy

Page 17: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.13b The Biology of Cancer (© Garland Science 2007)

Telomeric DNA shortens progressively as cells divide

telomere shorteningchromosomes fuse

apoptotic death

Telomeres lose 50 to 100 bp of DNA during each cell generation.

Page 18: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.13a The Biology of Cancer (© Garland Science 2007)

The length of telomeric DNA in cells(Southern blotting analysis)

Page 19: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.16 The Biology of Cancer (© Garland Science 2007)

10.5 Telomeres are complex molecular structures that are not easily replicated

Telomeric DNA:

5’-TTAGGG-3’ hexanucleotide sequence, tandemly repeated thousands of times

Page 20: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Telomeric DNAs_____________________________________________________

Telomeric repeat Organism sequence

_____________________________________________________

Yeasts

Saccharomyces cerevisiae G1-3T

Schizosaccharomyces pombe G2-5TTAC

Protozoans

Tetrahymena GGGGTT Dictyostelium G1-8A

Plant

Arabidopsis GGGTTTA

Mammal

Human GGGTTA

______________________________________________

Page 21: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.17 The Biology of Cancer (© Garland Science 2007)

Structure of the T-loop

Page 22: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.19 The Biology of Cancer (© Garland Science 2007)

Multiple telomere-specific proteins bound to telomeric DNA

Page 23: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Pot1 binds the single- and double-stranded telomeric DNA in order to stabilize its structure

s.s. telomeric DNA

Figure 10.18 The Biology of Cancer (© Garland Science 2007)

Page 24: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Primers and the initiation of DNA synthesis

Page 25: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Primers and the initiation of DNA synthesis

this sequence is not replicated

Page 26: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

10.6 Incipient cancer cells can escape crisis by expressing telomerase

- Telomerase activity (elongate telomeric DNA) is clearly detectable in 85 to 90% of human tumor cell samples, while being present at very low levels in most types of normal human cells.

telomerase holoenzyme:

1. hTERT catalytic subunit 2. hTR RNA subunit

(At least 8 other subunits may exist in the holoenzyme but have not been characterized.)

Page 27: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

human telomerase reverse transcriptase

human telomerase-associated RNA

(template for hTERT)

Figure 10.23a The Biology of Cancer (© Garland Science 2007)

Page 28: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.22a The Biology of Cancer (© Garland Science 2007)

The sequence of the catalytic subunit of telomerase is homologous to various reverse transcriptases

ciliates:yeasts:

Page 29: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.21a The Biology of Cancer (© Garland Science 2007)

The TRAP assay (telomeric repeat amplification protocol)

(in cell lysates)

+ dNTP

a synthetic primer

Page 30: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

The products of the TRAP reaction are analyzed by gel electrophoresis

heat treatment of cell lysates (inactivating telomerase activity)

Page 31: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.24 The Biology of Cancer (© Garland Science 2007)

Activation of telomerase activity following escape from crisis

Page 32: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Sidebar 10.5 Oncoproteins and tumor suppressor proteins play critical roles in governing hTERT expression

- The mechanisms that lead to the de-repression of hTERT transcription during tumor progression in humans are complex and still quite obscure.

- Multiple transcription factors appear to collaborate to activate the hTERT promoter.

- For example, the Myc protein (Section 8.9) and Menin (the product of the MEN1 tumor suppressor gene), deregulate the cell clock.

Page 33: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.25 The Biology of Cancer (© Garland Science 2007)

Prevention of crisis by expression of telomerase

HEK: human embryonic kidney cells

Page 34: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Sidebar 10.6 The role of telomeres in replicative senescence

- In cultured human fibroblasts, senescence can be postponed by expressing hTERT prior to the expected time for entering replicative senescence.

- However, senescence is also observed in cells that still possess quite long telomeres.

Why?

Page 35: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Possible explanations:

- When cells encounter cell-physiologic stress or the stress of tissue culture, telomeric DNA loses many of the single-stranded overhangs at the ends. The resulting degraded telomeric ends may release a DNA damage signal, thereby provoking a p53-mediated halt in cell proliferation that is manifested as the senescent growth state

Page 36: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.26 The Biology of Cancer (© Garland Science 2007)

Replicative senescence and the actions of telomerase

This is a still-speculative mechanistic model of how and why telomerase expression can prevent human cells from entering into replicative senescence.

Page 37: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

10.7 Telomerase plays a key role in the proli- feration of human cancer cells

- Expression of antisense RNA in the telomerase (+) HeLa cells causes them stop growing 23 to 26 days.

- Expression of the dn (dominant negative) hTERT subunit in telomerase (+) human tumor cell lines also causes them to lose all detectable telomerase activity and, with some delay, to enter crisis.

Page 38: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Suppression of telomerase results in the loss of the neoplastic growth in 4 different human cancer cell lines

Figure 10.27 The Biology of Cancer (© Garland Science 2007)

(length of telomeric DNA at the onset of the experiment)

Page 39: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 4.11

Telomerase activity and the prognosis of pediatric tumors

Figure 10.28 The Biology of Cancer (© Garland Science 2007)

Page 40: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

10.8 Some immortalized cells can maintain telomeres without telomerase

- 85 to 90% of human tumors have been found to be telomerase-positive.

- The remaining 10 to 15% lack detectable telomerase activity, yet these cells need to maintain their telomeres above some minimum length in order to proliferate indefinitely.

- These cells obtain the ability to maintain their telomeric DNA using a mechanism that does not depend on the actions of telomerase.

Page 41: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

- In the yeast Saccharomyces cervisiae, following inactivation of genes encoding subunits of the telomerase holoenzyme, the vast majority of the cells enter a state of crisis and die.

- Rare variants emerged from these populations of dying cells that used the alternative lengthening of telomerase (ALT) mechanism to construct and maintain their telomeres.

- This ALT mechanism is also used by the minority of human tumor cells that lack significant telomerase activity, e.g., 50% osteosarcomas and soft-tissue sarcomas and many glioblastomas.

Page 42: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.30 The Biology of Cancer (© Garland Science 2007)

The ALT (alternative lengthening of telomerase ) mechanism (or copy-choice mechanism)

Page 43: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.29 The Biology of Cancer (© Garland Science 2007)

neomycin-resistant gene was introduced into the midst of the telomeric DNA

Exchange of sequence information between the telomeres of different chromosomes

Page 44: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

10.9 Telomeres play different roles in the cells of laboratory mice and in human cells

- Rodent cells, especially those of the laboratory mouse strains, express significant levels of telomerase throughout life.

- The double-stranded region of mouse telomeric DNA is as much as 30 to 40 kb long (~ 5 times longer than corresponding human telomeric DNA).

- Therefore, laboratory mice do not rely on telomere length to limit the replicative capacity of their normal cell lineages and that telomere erosion cannot serve as a mechanism for constraining tumor development in these rodents.

Page 45: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Sidebar 10.8 Long telomeres (in mice) do not suffice for tumor formation

- Transgenic mice expressing mTERT (mouse homolog of telomerase reverse transcriptase) contributes to tumorigenesis even though the mouse cells in which this enzyme acts already possess very long (>30 kb) telomeres.

- Thus, the mTERT enzyme aids tumorigenesis through mechanisms other than simple telomere extension.

Page 46: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

- Mouse cells can be immortalized relatively easily following extended propagation in culture.

- Human cells require, instead, the introduction of both the SV40 large T oncogene (to avoid senescence) and the hTERT gene (to avoid crisis).

Page 47: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

SV40 and T antigens

- If the SV40 large T oncoprotein is expressed in human fibroblasts, these cells will continue to replicate another 10 to 20 cell generations and then enter crisis.

- On rare occasion, a small propotion of cells (1 out of 106 cells) will proceed to proliferate and continue to do indefinitely → becoming immortalized.

Page 48: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Table 3.1 The Biology of Cancer (© Garland Science 2007)

SV40: the 40th simian virus in a series of isolates

papovavirus: papilloma, polyoma & vacuolating agent

Page 49: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 3.10 The Biology of Cancer (© Garland Science 2007)

SV40 virus

SV40 launches a lytic cycle in monkey kidney cells

(permissive host)

formation of large cytoplasmic vacuoles prior to the death of the cell and the release of progeny virus particles

- vacuolating agent

Page 50: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

3.6 DNA Tumor virus genomes persist in virus- transformed cells by becoming part of host cell DNA

Figure 3.11 & 18 The Biology of Cancer (© Garland Science 2007)

Cell transformation by SV40 depend on the integration of SV40 genome into host cell DNA and the continued presence of T (tumor-associated) antigens.

- large T , middle T & small T Ags

double-stranded, circular DNA of SV40 (5 kb)

Page 51: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

Figure 10.8 The Biology of Cancer (© Garland Science 2007)

SV40 large T antigen can circumvent senescence

HEK: human embryonic kidney cells

Page 52: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

HEK 293

- HEK 293 cells were generated by transformation of normal human embryonic kidney (HEK) cells with adenovirus 5 DNA in the late 1977.

- HEK 293T cell line contains, in addition, the SV40 large T antigen, that allows for episomal replication of transfected plasmids containing the SV40 origin of replication. This allows for amplification of transfected plasmids and expression of the desired gene products.

Page 53: Chapter 10 Eternal Life: Cell Immortalization and Tumorigenesis -10.1 ~ 10.9 - May 1, 8 & 15, 2007.

mTR -/- mice exhibit no telomerase activity in any of their cells. They are indistinguishable phenotypically from wild-type mice for at least 3 generations.

Figure 10.31 The Biology of Cancer (© Garland Science 2007)

The progeny in the 6th generation show a diminished capacity to heal wounds, to respond properly to mitogenic signals, and suffer from substantially reduced fertility and tissue atrophy (loss of cells).

showing premature aging: - wasting away of muscle tissues & a hunched back